Antiarrhythmic effects and mechanisms of sodium-glucose cotransporter 2 inhibitors: A mini review
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a new type of oral hypoglycaemic agent with good cardiovascular protective effects. There are several lines of clinical evidence suggest that SGLT2i can significantly reduce the risks of heart failure, cardiovascular death, and delay the progres...
Main Authors: | Jinchun Wu, Yanmin Liu, Xiaojuan Wei, Xiaofei Zhang, Yi Ye, Wei Li, Xiaoling Su |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.915455/full |
Similar Items
-
Increased in vivo perpetuation of whole-heart ventricular arrhythmia in heterozygous Na+/Ca2+ exchanger knockout mice
by: Nils Bögeholz, et al.
Published: (2023-02-01) -
Distinct Effects of Mitochondrial Na+/Ca2+ Exchanger Inhibition and Ca2+ Uniporter Activation on Ca2+ Sparks and Arrhythmogenesis in Diabetic Rats
by: Sathya Velmurugan, et al.
Published: (2023-07-01) -
Sodium Transporters in Human Health and Disease
by: Kenneth B. Gagnon, et al.
Published: (2021-02-01) -
Antiarrhythmic and Inotropic Effects of Selective Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger Inhibition: What Can We Learn from the Pharmacological Studies?
by: Norbert Nagy, et al.
Published: (2022-11-01) -
SAR296968, a Novel Selective Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger Inhibitor, Improves Ca<sup>2+</sup> Handling and Contractile Function in Human Atrial Cardiomyocytes
by: Philipp Hegner, et al.
Published: (2022-08-01)